CRINETICS PHARMACEUTICALS IN (CRNX) Institutional Ownership Changes & 13F Activity
CRINETICS PHARMACEUTICALS IN (CRNX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Farallon Capital Management Llc, Polar Capital Holdings Plc, Wellington Management Group Llp, Price T Rowe Associates Inc, and Bellevue Group Ag.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -21,732 | -14.7% | 125,948 | $4.71M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -179,605 | -56.5% | 138,329 | $5.18M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -3,334 | -3.2% | 102,229 | $3.83M | Q2 2026 | Aug 24, 2026 |
| Capstone Investment Advisors, Llc | Sell | -1,905 | -21.1% | 7,107 | $265.94K | Q2 2026 | Aug 17, 2026 |
| Farallon Capital Management Llc | Buy | +8,989,098 | — | 8,989,098 | $336.37M | Q2 2026 | Aug 14, 2026 |
| Polar Capital Holdings Plc | Buy | +2,274,411 | — | 2,274,411 | $85.11M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Sell | -1,026,120 | -12.6% | 7,131,084 | $266.85M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +857,185 | +16.0% | 6,212,681 | $232.48M | Q2 2026 | Aug 14, 2026 |
| Bellevue Group Ag | Sell | -660,000 | -20.1% | 2,620,000 | $98.04M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +616,946 | +86.2% | 1,333,071 | $49.88M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +497,205 | — | 497,205 | $18.61M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +476,843 | +75.9% | 1,104,998 | $41.35M | Q2 2026 | Aug 14, 2026 |
| Kennedy Capital Management Llc | Buy | +365,714 | — | 365,714 | $13.69M | Q2 2026 | Aug 14, 2026 |
| First Light Asset Management, Llc | Buy | +271,196 | +24.9% | 1,360,866 | $50.92M | Q2 2026 | Aug 14, 2026 |
| Defilade Capital Management, L.P. | Buy | +239,440 | — | 239,440 | $8.96M | Q2 2026 | Aug 14, 2026 |
| Novo Holdings A/S | Sell | -230,000 | -14.8% | 1,320,000 | $49.39M | Q2 2026 | Aug 14, 2026 |
| Foresite Capital Management Iv, Llc | Buy | +150,000 | — | 150,000 | $5.61M | Q2 2026 | Aug 14, 2026 |
| Ishara Investments Lp | Buy | +143,500 | — | 143,500 | $5.37M | Q2 2026 | Aug 14, 2026 |
| Suvretta Capital Management, Llc | Buy | +142,400 | +13.6% | 1,186,279 | $44.39M | Q2 2026 | Aug 14, 2026 |
| Cormorant Asset Management, Lp | Sell | -125,000 | -50.0% | 125,000 | $4.68M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +116,460 | — | 116,460 | $4.36M | Q2 2026 | Aug 14, 2026 |
| Odyssean, Llc | Buy | +84,456 | — | 84,456 | $3.16M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +82,749 | +7.3% | 1,222,080 | $45.73M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +70,882 | — | 70,882 | $2.65M | Q2 2026 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +69,666 | +3.6% | 2,010,288 | $75.22M | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Buy | +67,629 | +1.1% | 6,463,551 | $241.87M | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +63,924 | +86.8% | 137,576 | $5.15M | Q2 2026 | Aug 14, 2026 |
| Hood River Capital Management Llc | Buy | +61,584 | +6.8% | 968,996 | $36.26M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +58,388 | — | 58,388 | $2.18M | Q2 2026 | Aug 14, 2026 |
| Lighthouse Investment Partners, Llc | Buy | +50,000 | — | 50,000 | $1.87M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about CRNX activity
Which institutional owners are buying CRNX?
Institutional owners buying CRNX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CRNX activity?
"Buy" means an investor increased their reported position in CRNX compared to the prior reporting period. This reflects growing exposure to CRINETICS PHARMACEUTICALS IN (CRNX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CRNX increasing?
Institutional interest in CRNX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CRNX Institutional Insights
- CRNX Overview
- CRNX 13F Institutional Holders
- CRNX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CRNX Insider Trading & SEC Form 4 Activity
- CRNX Articles
- Top Institutional Investor Stock Rankings